Meghmani Organics Q1 FY27 profit jumps 280% to ₹48.19 crore

Key takeaway from the June-quarter update

Meghmani Organics Limited reported a sharp year-on-year improvement in profitability for the quarter ended June 30, 2026 (Q1FY27), even as revenue fell. The company posted consolidated net profit of ₹48.19 crore, compared with ₹12.68 crore in Q1FY26, translating into about 280% growth. The update matters because it shows a margin-led recovery rather than a top-line driven one, with the company citing better operating efficiency and lower finance costs.

The board approved the unaudited standalone and consolidated financial results on July 29, 2026. The results were reviewed by the Audit Committee and were subjected to a limited review by statutory auditors Mukesh M. Shah & Co., Chartered Accountants.

Consolidated performance: profit up, revenue down

On a consolidated basis, revenue from operations came in at ₹542.83 crore in Q1FY27. This was an 11.54% year-on-year decline from ₹613.62 crore reported in Q1FY26. Despite the drop in revenue, profitability improved materially during the quarter.

Operating EBITDA rose to ₹97.90 crore in Q1FY27, up 46.3% year-on-year. The EBITDA margin expanded to 18% from 10.9% in the same quarter last year, reflecting a 710 bps improvement. The company also pointed to reduced finance costs as a driver of the stronger bottom line.

The consolidated net profit increased to ₹48.19 crore in Q1FY27 versus ₹12.68 crore in Q1FY26. The company’s communication also noted that the pigments segment returned to profitability during the quarter, supporting the broader recovery.

Standalone numbers: profit growth of 42%

On a standalone basis, Meghmani Organics reported net profit of ₹57.59 crore in Q1FY27. This represented a 42.2% year-on-year increase.

The company attributed the improvement to better operational efficiency and lower finance costs. While the release highlighted a strong improvement in profitability, it also underscored that the quarter was not supported by higher revenue, given the consolidated revenue decline.

Board approvals and regulatory framework

Meghmani Organics said the board approved the unaudited financial results in line with Regulation 33(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also stated that the results were reviewed by the Audit Committee and underwent a limited review by the statutory auditors.

These steps are part of the standard compliance process for quarterly financial reporting among listed companies. The company’s filings also referenced compliance under SEBI Listing Regulations for related disclosures.

Company secretary appointment: Naresh Prajapati named KMP

Alongside the financial results, the board approved the appointment of Naresh Prajapati (Membership No.: A44816) as Company Secretary and Compliance Officer, effective July 29, 2026. The company said the appointment was made based on the recommendation of the Nomination and Remuneration Committee.

The company described Prajapati as a member of the Institute of Company Secretaries of India and a law graduate with 10 years of experience. It also stated that he has been appointed as Key Managerial Personnel.

Earnings call scheduled: July 30, 2026

Meghmani Organics announced a Q1 FY27 earnings call scheduled for Thursday, July 30, 2026, at 5:00 PM IST. The company said Chairman Ankit Patel and CFO G S Chahal will present the results.

The schedule was issued pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as an update to stakeholders regarding a discussion of the recently announced financial results. Arihant Capital Markets Ltd is facilitating the earnings call.

What management will likely be asked about

Given the quarter’s pattern of higher profit despite lower revenue, investor questions are likely to focus on the sustainability of the margin improvement and the specific cost levers behind the EBITDA expansion. With the company mentioning lower finance costs, the earnings call may also address the drivers behind the reduction.

Another area of focus is expected to be the pigments segment’s return to profitability. While the company noted the turnaround, it did not provide segment-level numbers in the disclosed highlights here, so the call may provide additional colour on segment performance and operating conditions.

Background: amalgamation approvals in June 2026

Separately, the company noted that in June 2026 it secured approval from equity shareholders and secured creditors for a scheme of amalgamation. Under the scheme, its wholly-owned subsidiaries Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited are proposed to be merged into Meghmani Organics.

Such steps typically aim to simplify group structure and consolidate operations, although the company’s update in this context only refers to the approvals secured and does not provide additional financial impact details.

Key numbers at a glance

Earnings call access details shared by the company

Market impact and why the quarter stands out

The quarter’s headline is the sharp rebound in consolidated profit alongside an 11.54% decline in consolidated revenue. This combination puts attention on operating leverage, cost discipline, and finance-cost trends rather than demand-led growth.

The reported 710 bps EBITDA margin expansion to 18% is also central, as it explains how earnings improved when revenue fell. In addition, the company’s statement that the pigments segment returned to profitability adds a segment-level operational marker for investors tracking cyclical recovery within the portfolio.

Conclusion

Meghmani Organics ended Q1FY27 with consolidated net profit of ₹48.19 crore, supported by higher EBITDA, margin expansion, and lower finance costs despite lower revenue. The company also announced a key governance change with the appointment of Naresh Prajapati as Company Secretary and Compliance Officer effective July 29, 2026. The next immediate event for investors is the company’s Q1FY27 earnings call scheduled for July 30, 2026 at 5:00 PM IST, where management is expected to discuss the quarter’s operating drivers in more detail.